支气管肺癌的发病率及死亡率在欧美国家及我国工业较发达的地区已跃居恶性肿瘤的首位,其发病原因尚不完全清楚,且治疗手段有限,治愈率及五年生存率低。性激素受体在乳腺癌、前列腺癌等疾病中的研究进展促进了肺癌性激素受体的研究。 The morbidity and mortality of bronchial lung cancer have ranked first in malignant tumors in European and American countries and in areas where China’s industry is more developed. The causes of bronchial cancer are not fully understood, and the treatment methods are limited. The cure rate and five-year survival rate are low. The research progress of sex hormone receptors in breast cancer, prostate cancer and other diseases has promoted the study of sex hormone receptors in lung cancer.